Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114750) titled 'Iguratimod for Knee Osteoarthritis: A Study on Efficacy and Safety' on Dec. 17, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Beijing Jishuitan Hospital, Capital Medical University
Condition:
knee osteoarthritis
Intervention:
Group1:Meloxicam tablets and Iguratimod
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2025-12-19
Target Sample Size: Group1:300;Group2:300;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=301097
Published by HT Digital Content Services with permission from Health Dail...